Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Start-ups

CRISPR diagnostics company Mammoth launches

by Ryan Cross
May 6, 2018 | A version of this story appeared in Volume 96, Issue 19

 

Mammoth Biosciences is the latest biotech start-up to launch centered on CRISPR gene-editing technology. Rather than use CRISPR as a therapy, Mammoth plans to develop diagnostics that use CRISPR to detect diseases, including bacterial and viral infections, cancer, and genetic conditions. The system uses enzymes called Cas12 or Cas13 to recognize and cut disease-associated DNA or RNA, respectively, which will be represented by a color change on a paper-based test. The company was cofounded by Jennifer Doudna, a scientist at the University of California, Berkeley, who is one of the inventors of CRISPR gene editing.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.